GLORIA PHARMA.(SZ:002437) Xin Lang Cai Jing·2025-08-27 02:23Core Insights - Yuheng Pharmaceutical (002437.SZ) reported a total operating revenue of 1.1 billion yuan for the first half of 2025, ranking 37th among disclosed peers [1] - The company's net profit attributable to shareholders reached 134 million yuan, marking a year-on-year increase of 9.45 million yuan, or 7.56%, achieving three consecutive years of growth [1] - The net cash inflow from operating activities was 155 million yuan, ranking 33rd among disclosed peers [1] Financial Metrics - The latest debt-to-asset ratio is 28.70%, ranking 46th among disclosed peers, down 3.27 percentage points from the previous quarter and 2.96 percentage points from the same period last year [3] - The latest gross profit margin stands at 47.29% [3] - The return on equity (ROE) is 6.56%, ranking 23rd among disclosed peers, with a slight increase of 0.06 percentage points year-on-year [3] - The diluted earnings per share (EPS) is 0.06 yuan, an increase of 0.01 yuan from the same period last year, reflecting a 10.25% year-on-year growth [3] - The total asset turnover ratio is 0.38 times, ranking 9th among disclosed peers [3] - The inventory turnover ratio is 3.23 times, ranking 5th among disclosed peers, with an increase of 0.24 times year-on-year, achieving five consecutive years of growth [3] Shareholder Structure - The number of shareholders is 104,400, with the top ten shareholders holding a total of 490 million shares, accounting for 21.80% of the total share capital [3] - The top shareholders include: 1. Shen Zhenyu - 49.2 million shares 2. Guotai Junan Securities Co., Ltd. - 48.4 million shares 3. Yu Heng International Investments Corporation - 25.3 million shares 4. Oriental Keystone Investment Limited - 19.1 million shares 5. Hong Kong Central Clearing Limited - 13.9 million shares 6. Shanghai Fangyuan Dachuang Investment Partnership (Limited Partnership) - 13.7 million shares 7. Shanghai Fangyuan Dachuang Investment Partnership (Limited Partnership) - 13.5 million shares 8. Shanghai Fangyuan Dachuang Investment Partnership (Limited Partnership) - 12.7 million shares 9. Shanghai Fangyuan Dachuang Investment Partnership (Limited Partnership) - 12.5 million shares 10. Guoqi Ling - 9.8 million shares [3]